NASDAQ:IOVA

Iovance Biotherapeutics Stock Predictions

etoro logo Buy IOVA
*Your capital is at risk
$3.79
-0.310 (-7.56%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

IOVA Prediction Chart

IOVA Predictions History

Latest community submissions for IOVA.
Predictor Target Session Target Price Result Direction Accuracy Score
Jan 27, 2026 Bullish $2.98 V 1
Jan 27, 2026 $4.16 +43.94% $2.98 V 60.40% 1
Jan 26, 2026 $2.67 +0.95% $2.89 V 92.39% 1
Jan 20, 2026 $2.43 +3.03% $2.44 V 99.65% 5
Jan 20, 2026 $2.40 +1.89% $2.44 V 98.55% 2
Jan 20, 2026 Bullish $2.44 V 1
Jan 16, 2026 Bullish $2.36 V 1
Jan 15, 2026 $2.45 +3.00% $2.22 X 89.58% 0
Jan 15, 2026 $2.42 +1.87% $2.22 X 90.78% 0
Jan 15, 2026 Bullish $2.22 X 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for IOVA with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT IOVANCE BIOTHERAPEUTICS, INC.
Iovance Biotherapeutics
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment of metastatic melanoma; C-145-04, of its product candidate lifileucel for recurrent, metastatic, or pers...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE